Practice Management News

The estimated prevalence of autism among 8-year-olds in a New Jersey study more than tripled during a 6-year period, including a fivefold increase in children with autism who do not have a co-occurring intellectual disability.

A biopharmaceutical company announced the first participants have been dosed in its phase 1 clinical trial of PH10, an investigational pherine nasal spray to treat major depressive disorder.

The needs of families are largely unmet when a parent is hospitalized for a mental illness, with the need for a broad range of care models required to address these gaps, according to a study published in BMC Psychiatry.

Buprenorphine dispensing among youths decreased significantly from 2015 to 2020 despite a rise in opioid-related overdoses, according to a study published in Pediatrics.

A physician-owned acute care practice and a virtual psychiatry and therapy practice have announced a partnership that aims to provide comprehensive acute medical and psychiatric care services to EDs across the country.

Adverse childhood experiences, such as having a depressive episode or suffering physical abuse, were likely to contribute to risky drinking among children of alcoholics, researchers wrote in BMC Psychiatry.

Sleep quality in patients with type 1 diabetes may be improved with disease management as well as interventions supporting resilience and reducing negative emotions, researchers reported in BMC Psychiatry.

Individuals with mental disorders who attempted suicide were reported to have impaired or abnormal social decision-making, evidenced by neuro-electrophysiological activity, according to a study published in BMC Psychiatry.

New Directions Behavioral Health and Tridiuum have merged to form Lucet, a behavioral health optimization company.

The FDA has accepted and granted priority review to Purdue Pharma’s abbreviated new drug application for the opioid antagonist nalmefene hydrochloride injection 2 mg/2 mL prefilled syringes, the company announced in a press release.